The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival-Reference-Cited by-同舟云学术

The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival

Published:2013-12-18 Issue:1 Volume:28 Page:120-126
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Smedbråten Yuliya V.¹,Sagedal Solbjørg¹,Leivestad Torbjørn²,Mjøen Geir¹,Osnes Kåre³,Rollag Halvor⁴⁵,Reisaeter Anna V.²,Foss Aksel²⁵,Os Ingrid¹⁵,Hartmann Anders²⁵

Affiliation:

1. Department of Nephrology Ullevål; Oslo University Hospital; Oslo Norway

2. Department of Transplant Medicine Rikshospitalet; Oslo University Hospital; Oslo Norway

3. Department of Neuropsychiatry and Psychosomatic Medicine Rikshospitalet; Oslo University Hospital; Oslo Norway

4. Institute of Medical Microbiology Rikshospitalet; Oslo University Hospital; Oslo Norway

5. Faculty of Medicine; University of Oslo; Oslo Norway

Publisher

Wiley

Subject

Transplantation

Reference15 articles.

1. A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients;Sagedal;Transplantation,2000

2. Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation;Hjelmesaeth;Diabetologia,2004

3. Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial;Kliem;Am J Transplant,2008

4. Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report;Opelz;Am J Transplant,2004

5. The natural course of cytomegalovirus infection and disease in renal transplant recipients;Hartmann;Transplantation,2006

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Cost-effectiveness of Valganciclovir Prophylaxis Versus Preemptive Therapy in CMV R+ Kidney Transplant Recipients Over the First Year Posttransplantation;Transplantation Direct;2024-07-26

2. Cellular immunity against cytomegalovirus and risk of infection after kidney transplantation;Frontiers in Immunology;2024-06-28

3. Anti-Donor T-Cell Responses Are Not Necessarily Attenuated During Cytomegalovirus Infection in Kidney Transplant Recipients;Transplantation Proceedings;2024-04

4. Five‐year single‐center analysis of cytomegalovirus viremia in kidney transplant recipients and possible implication for novel prophylactic therapy approaches;Transplant Infectious Disease;2024-01-05

5. Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management;Transplantation;2023-07-20